Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. 01801
01801 logo

01801 Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
84.600
Open
82.100
VWAP
81.95
Vol
8.24M
Mkt Cap
--
Low
80.400
Amount
675.31M
EV/EBITDA(TTM)
65.36
Total Shares
--
EV
17.10B
EV/OCF(TTM)
56.75
P/S(TTM)
10.80

Events Timeline

(ET)
2025-12-07
21:00:00
Innovent Biologics Announces Initial Data of IBI3003 Clinical Trial
select
2025-12-01 (ET)
2025-12-01
03:52:00
Innovent Biologics Joins Hang Seng Index as First Biopharma Blue-Chip
select

News

aastocks
4.5
03-12aastocks
<Daily Summary> HSI Ends at 25,716, Dropping 182 Points; HSTI Finishes at 5,027, Down 27 Points; CSPC PHARMA Falls by More than 4%; CNOOC, CHINA SHENHUA, CHINA RISUN GP, QINGSONG HEALTH, and 160 HEALTH Reach New Peaks; Market Trading Volume Increases
  • Market Performance: The Hang Seng Index (HSI) fell by 182 points (0.7%) to close at 25,716, while the Hang Seng Tech Index (HSTI) and the Hang Seng China Enterprises Index (HSCEI) also experienced declines.

  • Active Heavyweights: Major stocks like Alibaba, Tencent, and Meituan saw slight declines, with Alibaba closing at $131.6 (-1.2%) and Tencent at $546.5 (-1%).

  • Notable Movers: Xpeng and JD Logistics were among the gainers, with Xpeng rising 4.4% to $78.45, while CSPC Pharma and Nongfu Spring faced significant losses, dropping 4.5% and 4.4%, respectively.

  • Short Selling Trends: High short selling ratios were observed in several stocks, including Meituan (46.5%) and Nongfu Spring (53.8%), indicating increased bearish sentiment among investors.

aastocks
4.5
03-10aastocks
<Daily Summary> HSI Gains 551 Points; HSTI Rises 118 Points; TENCENT Surges Over 7%; BABA Increases Over 3%; XUNCE, HAIXI PHARMA, AB&B BIO-TECH-B, JIAXIN INTL RES, LINGBAOGOLD-100 Reach New Peaks; Market Activity Increases
  • Market Performance: The Hang Seng Index (HSI) rose by 551 points (2.2%) to close at 25,959, with significant gains also seen in the HSTI and HSCEI, reflecting a strong market turnover of $330.93 billion.

  • Top Gainers: Notable heavyweights like Tencent and Alibaba saw substantial increases, with Tencent up 7.3% and Alibaba up 3.7%, while CATL led the HSI constituents with a 9.3% rise.

  • Active Stocks: Other active stocks included SMIC and AIA, which rose by 5.5% and 4.7% respectively, while Xiaomi experienced a slight decline of 0.2%.

  • Significant Movers: Among smaller stocks, QUANTGROUP and XUNCE had remarkable gains of 34.3% and 32.9%, respectively, while DEEPEXI TECH faced a significant drop of 17.9%.

aastocks
4.5
03-10aastocks
HSI Rises 396 Points at Midday; TENCENT Increases by 5.7%; CATL Surges Over 8% After Earnings Report
  • US Market Performance: The DJIA rose by 239 points (0.5%) and the Nasdaq increased by 1.4% following President Trump's announcement regarding the Iran war's imminent end.

  • Hong Kong Stock Market: The HSI opened 331 points higher and closed up 396 points (1.6%), with significant gains in tech stocks like MINIMAX-WP and KNOWLEDGE ATLAS.

  • Tech Stock Trends: AI stocks continued to surge, with MINIMAX-WP and KNOWLEDGE ATLAS seeing increases of 9.5% and 6.9%, respectively, while TENCENT also experienced a notable rise.

  • Sector Performance: Pharmaceuticals and chip stocks showed strong performance, with several companies like 3SBIO and ILUVATAR COREX posting significant gains, while some automakers faced declines.

aastocks
4.5
03-10aastocks
<Midday Update> HSI Rises by 396 Points; HSTI Gains 69 Points; TENCENT Surges Over 5%; BABA Increases Over 3%; LINGBAOGOLD-100 and HUISHANG BANK Reach New Peaks
  • Market Performance: The Hang Seng Index (HSI) rose by 396 points (1.6%) to 25,804, while the Hang Seng Tech Index (HSTI) and the Hang Seng China Enterprises Index (HSCEI) also saw gains of 69 points (1.4%) and 91 points (1.1%) respectively.

  • Top Gainers: Notable gainers included TENCENT (+5.7% to $545.5), BABA (+3% to $132.6), and CATL (+8.7% to $547), with significant short selling activity reported for these stocks.

  • Decliners: DEEPEXI TECH experienced a sharp decline of 18.6%, closing at $88.25, while other stocks like XIAOMI and MEITUAN also saw slight decreases.

  • Short Selling Trends: High short selling ratios were observed in several stocks, including XIAOMI (32.91%) and MEITUAN (34.52%), indicating investor caution or bearish sentiment in these companies.

aastocks
4.5
03-06aastocks
<Daily Summary> HSI Gains 435 Points; HSTI Rises 151 Points; XIAOMI, BABA, and TENCENT Each Increase by Over 3%; Market Turnover Increases
  • Market Performance: The Hang Seng Index (HSI) rose by 435 points (1.7%) to close at 25,757, with significant gains also seen in the HSTI and HSCEI, which increased by 151 points (3.2%) and 176 points (2.1%) respectively, and market turnover reached $292.77 billion.

  • Top Gainers: Notable heavyweights like Xiaomi, Alibaba, and Tencent saw increases of 3.8%, 3.5%, and 3.4% respectively, while JD Logistics surged by 22.98%, and JD gained 9.95%.

  • Short Selling Activity: High short selling ratios were observed in several stocks, with JD having a ratio of 43.477% and Meituan at 26.184%, indicating significant market speculation.

  • Other Notable Stocks: Companies like Geely Auto, Trip.com, and Mengniu Dairy also experienced substantial gains, with increases of 7.9%, 7.2%, and 6.9% respectively, reflecting a positive trend in various sectors.

aastocks
4.5
03-06aastocks
<Midday Update> HSI Rises by 468 Points; HSTI Gains 177 Points; XIAOMI Surges Over 5%; BABA Increases Over 4%; TENCENT Climbs Over 3%
  • Market Performance: The Hang Seng Index (HSI) rose by 468 points (1.9%) to 25,789, while the Hang Seng Tech Index (HSTI) increased by 177 points (3.7%) to 4,973, and the Hang Seng China Enterprises Index (HSCEI) gained 187 points (2.2%) to 8,638.

  • Top Gainers: Notable stock performances included JD Logistics, which surged 21.3%, JD up 8.5%, and Trip.com rising 7.0%. Major companies like Xiaomi, Alibaba, and Tencent also saw significant increases in their stock prices.

  • Short Selling Activity: High short selling volumes were reported for several stocks, with Alibaba and JD having short selling ratios of 16.072% and 50.972%, respectively, indicating investor caution despite their price increases.

  • Other Notable Movements: Stocks like TransThera and Bayzed Health experienced substantial gains of 34.9% and 21.5%, respectively, while Chinahongqiao saw a decline of 3.3%, reflecting varied performance across different sectors.

Wall Street analysts forecast 01801 stock price to rise
0 Analyst Rating
Wall Street analysts forecast 01801 stock price to rise
0 Buy
0 Hold
0 Sell
Current: 0.000
sliders
Low
Averages
High
Current: 0.000
sliders
Low
Averages
High
M Stanley
M Stanley
Overweight
initiated
$130
AI Analysis
2026-03-03
Reason
M Stanley
M Stanley
Price Target
$130
AI Analysis
2026-03-03
initiated
Overweight
Reason
The analyst ratings and their reasons from the article are as follows: 1. EVEREST MED (01952.HK): Rated Equalweight with a target price decrease from 55 to 44. The rating suggests a neutral outlook on the stock, likely due to its recent performance and short selling activity. 2. INNOVENT BIO (01801.HK): Rated Overweight with a target price of 130. The article mentions that Morgan Stanley has reinitiated coverage on this stock, indicating a positive outlook and potential catalysts for the Chinese biotech sector in the second half of 2026. 3. VISEN PHARMA-B (02561.HK): Rated Overweight with a target price decrease from 80 to 50. The downgrade in target price may reflect concerns about the stock's recent performance despite maintaining an overall positive rating. 4. ZAI LAB (09688.HK): Rated Overweight with a target price decrease from 37.5 to 19.5. Similar to VISEN PHARMA, the reduction in target price suggests some caution, but the overall rating remains positive. Overall, the ratings reflect a mix of cautious optimism and adjustments based on recent performance and market conditions, particularly for INNOVENT BIO, which has a more favorable outlook due to anticipated catalysts.
Morgan Stanley
Morgan Stanley
initiated
HKD130
2026-03-03
Reason
Morgan Stanley
Morgan Stanley
Price Target
HKD130
2026-03-03
initiated
Reason
The analyst rating from Morgan Stanley is based on several key factors regarding China's biotech sector. They note that the sector is at a turning point with stabilizing fundamentals, a resilient innovation base, ongoing licensing transactions, and a recovery in financing activities. However, in the first half of 2026 (1H26), the market is expected to experience limited high-conviction investment themes and unstable risk appetite due to a lack of catalysts and increasing geopolitical uncertainties. Morgan Stanley anticipates that the biotech sector will face allocation pressure and range-bound fluctuations in 1H26, but they expect that catalysts, capital reallocation, and more favorable valuations will set the stage for clearer stock price direction in the second half of 2026 (2H26). They believe that the next growth phase will begin with meaningful data releases and increased visibility in business development and licensing transactions, which are expected to occur in 2H26. As a result, Morgan Stanley has reinitiated coverage on INNOVENT BIO with an Overweight rating and a target price of HKD130, indicating their positive outlook for the stock in light of these anticipated developments.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for 01801
Unlock Now

Valuation Metrics

The current forward P/E ratio for (01801.HK) is 50.91, compared to its 5-year average forward P/E of 83.16. For a more detailed relative valuation and DCF analysis to assess 's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
83.16
Current PE
50.91
Overvalued PE
541.70
Undervalued PE
-375.39

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-40.36
Current EV/EBITDA
63.34
Overvalued EV/EBITDA
129.68
Undervalued EV/EBITDA
-210.39

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
9.33
Current PS
8.00
Overvalued PS
13.71
Undervalued PS
4.94

Financials

AI Analysis
Annual
Quarterly

Whales Holding 01801

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is (01801) stock price today?

The current price of 01801 is 81.05 USD — it has decreased -0.98

What is (01801)'s business?

What is the price predicton of 01801 Stock?

Wall Street analysts forecast 01801 stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for 01801 is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is (01801)'s revenue for the last quarter?

revenue for the last quarter amounts to NaN USD, decreased

What is (01801)'s earnings per share (EPS) for the last quarter?

. EPS for the last quarter amounts to USD, decreased

How many employees does (01801). have?

(01801) has 0 emplpoyees as of March 21 2026.

What is (01801) market cap?

Today 01801 has the market capitalization of 0.00 USD.